Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
@article{TAU41768, author = {Hyeong Dong Yuk and Chang Wook Jeong and Cheol Kwak and Hyeon Hoe Kim and Ja Hyeon Ku}, title = {Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy}, journal = {Translational Andrology and Urology}, volume = {9}, number = {3}, year = {2020}, keywords = {}, abstract = {}, issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/41768} }